Pharmaceutical research and development (R&D) – statistics & facts
Key insights
- Total global spending on R&D in 2022
- 244 bn USD
Detailed statistics
Total global pharmaceutical R&D spending 2014-2028
- Top pharma company by R&D spending in 2022
- Roche
Detailed statistics
Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
- Average cost of drug development in U.S.
- 2.6 bn USD
Detailed statistics
Pharmaceuticals: cost of drug development in the U.S. since 1975
Editor’s Picks Current statistics on this topic
Current statistics on this topic
Related topics
Recommended statistics
Overview
6
- Premium Statistic Total global pharmaceutical R&D spending 2014-2028
- Premium Statistic R&D spending growth worldwide on pharmaceuticals 2015-2028
- Premium Statistic Growth rate of R&D spending in pharmaceutical industry by major region 2007-2022
- Premium Statistic Number of drugs in the R&D pipeline worldwide 2001-2023
- Basic Statistic Pharma companies worldwide with active R&D pipelines 2001-2023
- Basic Statistic Projected most valuable R&D projects based on net present value 2023
Overview
-
Premium Statistic
Total global pharmaceutical R&D spending 2014-2028
Total global pharmaceutical R&D spending 2014-2028
Total global spending on pharmaceutical research and development from 2014 to 2028 (in billion U.S. dollars)
-
Premium Statistic
R&D spending growth worldwide on pharmaceuticals 2015-2028
R&D spending growth worldwide on pharmaceuticals 2015-2028
Global growth in total pharmaceutical R&D spending from 2015 to 2028
-
Premium Statistic
Growth rate of R&D spending in pharmaceutical industry by major region 2007-2022
Growth rate of R&D spending in pharmaceutical industry by major region 2007-2022
Annual growth of pharmaceutical R&D spending in Europe, the U.S., and China between 2007 and 2022
-
Premium Statistic
Number of drugs in the R&D pipeline worldwide 2001-2023
Number of drugs in the R&D pipeline worldwide 2001-2023
Total number of drugs in the R&D pipeline worldwide from 2001 to 2023
-
Basic Statistic
Pharma companies worldwide with active R&D pipelines 2001-2023
Pharma companies worldwide with active R&D pipelines 2001-2023
Total number of pharmaceutical companies with active R&D pipelines worldwide from 2001 to 2023
-
Basic Statistic
Projected most valuable R&D projects based on net present value 2023
Projected most valuable R&D projects based on net present value 2023
Selected top pharmaceutical R&D projects based on net present value (NPV) as of December 2023 (in billion U.S. dollars)
R&D performance by company
5
- Premium Statistic R&D spending share of top pharmaceutical companies 2022
- Basic Statistic Top pharmaceutical companies in R&D spending growth 2022
- Basic Statistic Top 50 global pharmaceutical and biotech companies by R&D intensity in 2022
- Premium Statistic Top pharma companies worldwide 2023, by size of R&D pipeline
- Premium Statistic Distribution of pharmaceutical R&D companies by region 2023
R&D performance by company
-
Premium Statistic
R&D spending share of top pharmaceutical companies 2022
R&D spending share of top pharmaceutical companies 2022
R&D spending as revenue share of leading 10 pharmaceutical companies in 2022
-
Basic Statistic
Top pharmaceutical companies in R&D spending growth 2022
Top pharmaceutical companies in R&D spending growth 2022
World's top 50 pharmaceutical and biotechnology companies based on R&D spending growth in 2022
-
Basic Statistic
Top 50 global pharmaceutical and biotech companies by R&D intensity in 2022
Top 50 global pharmaceutical and biotech companies by R&D intensity in 2022
World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022
-
Premium Statistic
Top pharma companies worldwide 2023, by size of R&D pipeline
Top pharma companies worldwide 2023, by size of R&D pipeline
Leading 15 pharmaceutical companies worldwide by size of R&D pipeline as of 2023
-
Premium Statistic
Distribution of pharmaceutical R&D companies by region 2023
Distribution of pharmaceutical R&D companies by region 2023
Distribution of pharmaceutical R&D companies worldwide by country as of 2023
Characteristics of R&D pipeline
5
- Basic Statistic Top therapeutic categories worldwide 2023, by number of R&D products
- Premium Statistic Worldwide top diseases 2023, by number of active drugs
- Basic Statistic Worldwide top origins for pipeline drugs by number of active drugs 2023
- Basic Statistic Worldwide pipeline drugs by delivery route share 2023
- Basic Statistic Worldwide top drug producing mechanisms of action by number of active compounds 2023
Characteristics of R&D pipeline
-
Basic Statistic
Top therapeutic categories worldwide 2023, by number of R&D products
Top therapeutic categories worldwide 2023, by number of R&D products
Leading 15 therapeutic categories worldwide by number of R&D products as of 2023
-
Premium Statistic
Worldwide top diseases 2023, by number of active drugs
Worldwide top diseases 2023, by number of active drugs
Leading 15 diseases worldwide by number of active drugs as of 2023
-
Basic Statistic
Worldwide top origins for pipeline drugs by number of active drugs 2023
Worldwide top origins for pipeline drugs by number of active drugs 2023
Leading 15 origins of drugs in R&D pipeline worldwide by number of active drugs as of 2023
-
Basic Statistic
Worldwide pipeline drugs by delivery route share 2023
Worldwide pipeline drugs by delivery route share 2023
Percentage of drugs in R&D pipeline worldwide by delivery route as of 2023
-
Basic Statistic
Worldwide top drug producing mechanisms of action by number of active compounds 2023
Worldwide top drug producing mechanisms of action by number of active compounds 2023
Leading 15 mechanisms of action in R&D pipeline drugs worldwide by number of active compounds as of 2023
Duration, cost and ROI
4
- Basic Statistic Average length of a clinical trial cycle 2014-2022
- Basic Statistic Rate of return on biopharma R&D late stage pipeline 2013-2022
- Premium Statistic Average R&D cost to develop new biopharma compound 2013-2022
- Premium Statistic Average peak sales forecast per new biopharmaceutical asset 2013-2022
Duration, cost and ROI
-
Basic Statistic
Average length of a clinical trial cycle 2014-2022
Average length of a clinical trial cycle 2014-2022
Average length of a clinical trial cycle from 2014 to 2022 (in years)
-
Basic Statistic
Rate of return on biopharma R&D late stage pipeline 2013-2022
Rate of return on biopharma R&D late stage pipeline 2013-2022
Rate of return on biopharmaceutical late-stage R&D pipeline from 2013 to 2022
-
Premium Statistic
Average R&D cost to develop new biopharma compound 2013-2022
Average R&D cost to develop new biopharma compound 2013-2022
Average cost to develop a compound for biopharma companies from 2013 to 2022 (in billion U.S. dollars)
-
Premium Statistic
Average peak sales forecast per new biopharmaceutical asset 2013-2022
Average peak sales forecast per new biopharmaceutical asset 2013-2022
Projected average peak sales for each new biopharmaceutical asset from 2013 to 2022 (in million U.S. dollars)
Outsourced R&D
4
Outsourced R&D
-
Premium Statistic
CRO market size worldwide forecast 2028
CRO market size worldwide forecast 2028
Global contract research organization (CRO) market in 2023 and 2028 (in billion U.S. dollars)
-
Premium Statistic
Leading global contract research organizations based on revenue 2022
Leading global contract research organizations based on revenue 2022
Leading global contract research organizations (CROs) based on 2022 revenue (in million U.S. dollars)
-
Premium Statistic
CDMO market size worldwide forecast 2020-2030
CDMO market size worldwide forecast 2020-2030
Contract development and manufacturing organization (CDMO) market forecast worldwide from 2020 to 2030 (in billion U.S. dollars)
-
Basic Statistic
Top pharma contract development and manufacturing companies 2022
Top pharma contract development and manufacturing companies 2022
Leading 10 contract development and manufacturing organizations (CDMOs) based on revenue in 2022 (in billion U.S. dollars)
Public opinion/knowledge
6
- Basic Statistic Willingness to pay more taxes for additional medical research - U.S. adults 2019-2023
- Basic Statistic View of health research as a problem or solution for rising costs - U.S. adults 2020
- Basic Statistic Importance to support private investments in medical research by government 2022
- Premium Statistic U.S. approval of pharma companies' COVID-19 vaccine development handling 2021
- Basic Statistic Share of U.S. adults who could name a medical or health research entity 2023
- Basic Statistic Participation in clinical trials recommended by a doctor among U.S. adults 2021
Public opinion/knowledge
-
Basic Statistic
Willingness to pay more taxes for additional medical research - U.S. adults 2019-2023
Willingness to pay more taxes for additional medical research - U.S. adults 2019-2023
Would you be willing to pay $1 per week more in taxes if you were certain that all of the money would be spent on additional medical research?
-
Basic Statistic
View of health research as a problem or solution for rising costs - U.S. adults 2020
View of health research as a problem or solution for rising costs - U.S. adults 2020
When it comes to rising health care costs, would you say research to improve health is part of the problem or part of the solution?
-
Basic Statistic
Importance to support private investments in medical research by government 2022
Importance to support private investments in medical research by government 2022
How important is it for the federal government to support incentives for private sector investment in new treatments and cures?
-
Premium Statistic
U.S. approval of pharma companies' COVID-19 vaccine development handling 2021
U.S. approval of pharma companies' COVID-19 vaccine development handling 2021
Percentage of U.S. adults who approve of how pharmaceutical companies handled COVID-19 vaccine development as of 2021
-
Basic Statistic
Share of U.S. adults who could name a medical or health research entity 2023
Share of U.S. adults who could name a medical or health research entity 2023
Percentage of adults in the United States who could name a medical or health research entity as of 2023
-
Basic Statistic
Participation in clinical trials recommended by a doctor among U.S. adults 2021
Participation in clinical trials recommended by a doctor among U.S. adults 2021
How likely would you be to participate in a clinical trial recommended by your doctor?
Further reportsGet the best reports to understand your industry
Get the best reports to understand your industry
Contact
Get in touch with us. We are happy to help.
Meredith Alda
Sales Manager– Contact (United States)
Mon - Fri, 9am - 6pm (EST)
Yolanda Mega
Operations Manager– Contact (Asia)
Mon - Fri, 9am - 5pm (SGT)
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)
Mon - Fri, 10:00am - 6:00pm (JST)
Lodovica Biagi
Director of Operations– Contact (Europe)
Mon - Fri, 9:30am - 5pm (GMT)
Carolina Dulin
Group Director - LATAM– Contact (Latin America)
Mon - Fri, 9am - 6pm (EST)